Healthcare with Confidence
Immunotherapy for Leukemia in Israel
Immunotherapy is one of the most promising and innovative methods of leukemia treatment in Israel. It works by activating the patient’s own immune system to recognize and destroy cancer cells — often with far fewer side effects than traditional chemotherapy.
In Israel, leading hematologists and oncology experts offer both in-person and online consultations for patients seeking advanced immunological treatments for leukemia.
What Is Immunotherapy for Leukemia?
Leukemia is a cancer of the blood and bone marrow that affects both children and adults. It causes abnormal white blood cells to multiply uncontrollably, replacing healthy cells in the blood and bone marrow.
Immunotherapy helps the immune system detect and attack these cancer cells. Compared to chemotherapy or radiation, this method often provides better tolerance and longer-lasting remission, with many patients experiencing minimal or no side effects.
Israeli hematologists use immunotherapy as a standalone treatment or in combination with chemotherapy, radiation therapy, or targeted drugs, depending on the type and stage of leukemia.
⇒ Leading Hematologists – Consultation Online
Types of Leukemia Treated with Immunotherapy
- Acute Myeloid Leukemia (AML)
- Acute Lymphoblastic (Lymphocytic) Leukemia (ALL)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Hairy Cell Leukemia (HCL)
- T-Cell Prolymphocytic Leukemia (T-PLL)
- Large Granular Lymphocytic Leukemia (LGL)
Immunotherapy Drugs for Leukemia in Israel (FDA-Approved)
Israeli hospitals use the latest FDA-approved immunotherapy medications for leukemia, prescribed by top hematologists and clinical researchers:
- Stem Cell Transplantation – Restores bone marrow function after intensive therapy.
- Monoclonal Antibodies:
- Blinatumomab (Blincyto)
- Alemtuzumab (Campath)
- Obinutuzumab (Gazyva)
- Ofatumumab (Arzerra)
- Rituximab (Rituxan)
- Antibody-Drug Conjugates:
- Gemtuzumab Ozogamicin (Mylotarg)
- Rituximab with Hyaluronidase (Rituxan Hycela) – used for specific leukemia types.
- TAP (T-Cell Activated Therapy) – approved for children with acute lymphoblastic leukemia (ALL).
- CAR-T Cell Therapy – a revolutionary cellular immunotherapy now approved by the Israeli Ministry of Health after successful clinical trials in the USA, Europe, and the UK.
In addition, Israeli centers are participating in ongoing clinical trials of new immunotherapy drugs that have shown remarkable early results in resistant leukemia cases.
Why Choose Immunotherapy in Israel?
Israeli leukemia centers are globally recognized for their personalized approach, research excellence, and rapid adoption of new FDA and EMA protocols. Patients receive care guided by top hematologists, many of whom are listed in the Forbes Israel “Best Doctors” ranking.
Treatment is based on international protocols, and every program is adapted to your personal condition, age, and type of leukemia.
When to Consult an Israeli Hematologist
If you or your loved one has leukemia, you can get a second opinion or online consultation with an Israeli hematologist to find out:
- Whether immunotherapy is suitable in your specific case
- Whether more advanced treatments exist than your current one
- How to perform molecular and genomic tests for personalized therapy
- Costs of immunotherapy and precision medicine in Israel
- Reviews about the leading Israeli leukemia specialists
- Simply send your medical history, test results, and reports, and our coordinators will connect you with the right doctor.
- You will receive a professional answer within a few hours and personalized guidance on your next steps.
